Diabetes Trials in Kettering, United States
Conditions / Diabetes / Kettering, United States
Clinical trials for Diabetes investigate a range of treatment strategies and patient populations.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00097279 | Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00773279 | Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics | COMPLETED | PHASE3 |
| NCT02461589 | Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT00333151 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00518882 | Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02305381 | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00106366 | Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01336023 | Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00283751 | Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02128932 | Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |